[Skip to Content]
[Skip to Content Landing]
October 1985

Clearance of Triamcinolone From Vitreous

Author Affiliations

From the Department of Ophthalmology, Medical College of Wisconsin, Milwaukee.

Arch Ophthalmol. 1985;103(10):1567-1569. doi:10.1001/archopht.1985.01050100143037

• The clearance of intravitreally injected triamcinolone acetonide was monitored by both indirect ophthalmoscopy and high-performance liquid chromatography (HPLC) and found to be more rapid than previously reported by others. Twenty-four rabbits were intravitreally injected in each eye with 0.4 mg of triamcinolone acetonide. Three rabbits each were sacrificed at intervals ranging from one hour to 46 days. The vitreous was then harvested and processed for HPLC analysis. Triamcinolone and the internal standard prednisolone were identified and quantitated by the use of HPLC, which was found to be both sensitive and specific for the steroids. The half-life as determined by HPLC was 1.6 days, the level at 13 days postinjection was 66 ± 19 μg, and no drug was detectable by HPLC analysis at 21 days in five of six eyes. The intravitreal masses thought to be triamcinolone were clinically observable to an average of 23.3 days. The chromatographically determined clearance rate did not correlate well with clinical impressions based on indirect ophthalmoscopy.

Sugita G, Tano Y, Machemer R, et al:  Intravitreal autotransplantation of fibroblasts . Am J Ophthalmol 1980;89:121-130.
Tano Y, Chandler D, Machemer R:  Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide . Am J Ophthalmol 1980;90:810-816.
McCuen BW II, Bessler M, Tano Y, et al:  The lack of toxicity of intravitreally administered triamcinolone acetonide . Am J Ophthalmol 1981; 91:785-788.
Tano Y, Sugita G, Abrams G, et al:  Inhibition of intraocular proliferations with intravitreal corticosteroids . Am J Ophthalmol 1980; 89:131-136.
Tano Y, Chandler DB, McCuen BW II, et al:  Glucocorticoid inhibition of intraocular proliferation after injury . Am J Ophthalmol 1981;91:184-189.
Schindler RH, Chandler D, Thresher R, et al:  The clearance of intravitreal triamcinolone acetonide . Am J Ophthalmol 1982;93:415-417.
Bernstein S, Lenhard RH, Allen WS, et al:  The synthesis of the 16a-hydroxy derivatives of 9α-substituted steroids . J Am Chem Soc 1959;81:1689-1695.Article
Herzog HL, Payne CC, Jevnik MA, et al:  Synthesis and proof of structure of Δ1,4-pregnadiene-17α, 21-diol-3, 11,20 trione and Δ1,4-pregnadiene-11β, 17α, 21-triol-3, 20-dione . J Am Chem Soc 1955;77:4781-4784.Article
Chen C:  Methods of estimation of adrenal cortical steroids with tetrazolium salts . J Lab Clin Med 1953;42:749-757.
Kautsky MP: Steroid Analysis by HPLC, Recent Applications . New York, Marcel Dekker Inc, 1981, p 114.
Gordon G, Wood PR:  Determination of triamcinolone acetonide in cream and suspension formulations by high-performance liquid chromatography . Analyst 1976;101:876-882.Article
Agabeyoglu IT, Wagner JG, Kay DR:  A sensitive high-pressure liquid chromatographic method for the determination of prednisone, prednisolone and hydrocortisone in plasma . Res Comm Chem Pathol Pharmacol 1980;28:163-176.
Graham RO, Peyman GA:  Intravitreal injection of dexamethasone . Arch Ophthalmol 1974;92:149-154.Article
Maurice DM:  Injection of drugs into the vitreous body , in Leopold I, Burns R (eds): Symposium on Ocular Therapy . New York, John Wiley & Sons Inc, 1976, pp 59-71.
Topping TM, Abrams GW, Machemer R:  Experimental double-perforating injury of the posterior segment in rabbit eyes: The natural history of intraocular proliferation . Arch Ophthalmol 1979;97:735-742.Article